Advertisement
Skip to Content

MFS Emerging Markets Debt R3 MEDFX

Quantitative rating as of | See MFS Investment Hub
  • NAV / 1-Day Return 12.04  /  0.53 %
  • Total Assets 7.2 Bil
  • Adj. Expense Ratio
    1.050%
  • Expense Ratio 1.050%
  • Distribution Fee Level Low
  • Share Class Type Retirement, Medium
  • Category Emerging Markets Bond
  • Credit Quality / Interest Rate Sensitivity Low / Extensive
  • Min. Initial Investment 0
  • Status Open
  • TTM Yield 6.55%
  • Effective Duration 6.78 years

Morningstar’s Analysis MEDFX

Will MEDFX outperform in future?

Get our overall rating based on a fundamental assessment of the pillars below.

Summary

|

A strong management team and sound investment process underpin MFS Emerging Markets Debt R3's Morningstar Quantitative Rating of Bronze. Fees are a weakness here. The strategy's lofty fees are a high hurdle to clear, as it is priced within the second-costliest quintile among peers.

Unlock our full analysis with Morningstar Investor